Prolonged survival of patients withlung adenocarcinoma expressing XAGE-1b and HLA class I antigens

Cancer immunity

Akiko Uenaka¹  Masaharu Nishimura³  Satoshi Oizumi³  Eiichi Nakayama¹  Shuichiro Sato¹  Koichi Yamazaki³  Eiki Kikuchi³  Hirotoshi Dosaka-Akita²  Noriyuki Yamada³ 

[1]Department of Immunology, Okayama UniversityGraduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama700-8558, JapanDepartment of Immunology, Okayama UniversityGraduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama700-8558, JapanDepartment of Immunology, Okayama UniversityGraduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama700-8558, Japan

[2]Department of Medical Oncology, HokkaidoUniversity Graduate School of Medicine, North15 West 7, Kita-ku, Sapporo 060-8638, JapanDepartment of Medical Oncology, HokkaidoUniversity Graduate School of Medicine, North15 West 7, Kita-ku, Sapporo 060-8638, JapanDepartment of Medical Oncology, HokkaidoUniversity Graduate School of Medicine, North15 West 7, Kita-ku, Sapporo 060-8638, Japan

[3]First Department of Medicine, HokkaidoUniversity School of Medicine, North 15 West7, Kita-ku, Sapporo 060-8638, JapanFirst Department of Medicine, HokkaidoUniversity School of Medicine, North 15 West7, Kita-ku, Sapporo 060-8638, JapanFirst Department of Medicine, HokkaidoUniversity School of Medicine, North 15 West7, Kita-ku, Sapporo 060-8638, Japan

关键词: human;    non-smallcell lung cancer;    XAGE-1;    HLA class I antigen;    immunohistochemistry;    prognosis;   

DOI  :  

学科分类：肿瘤学

来源: Cancer immunity

【 授权许可】

Unknown